Prognostic Model – Medxy AI

Beyond Standard Staging: A Novel Genetics-Based Model Refines Prognosis for AML Patients Treated with Venetoclax and Hypomethylating Agents

By MedXY 02/14/2026

A newly developed prognostic model integrates mutational and cytogenetic data to accurately predict survival in AML patients receiving HMA/VEN therapy, offering superior risk stratification into low-, intermediate-, and high-risk categories with distinct survival durations.

Critical Care Gastroenterology news

Real-time Sepsis Risk Prediction in Acute Gastrointestinal Bleeding: A Validated Dynamic Monitoring Tool That Improves Early Stratification

By MedXY 12/02/2025

A multicenter Chinese study developed and validated a real-time nomogram that predicts sepsis in acute gastrointestinal bleeding (AGIB) using clinical and laboratory variables; the tool showed strong discrimination (AUCs 0.827–0.884), good calibration, and an online monitoring platform for dynamic alerts.

Dermatology news Rheumatology

Predicting Rare but Serious Harm: A Validated 100‑Day Risk Model for Allopurinol‑Induced Severe Cutaneous Adverse Reactions

By MedXY 12/01/2025

A large UK cohort study developed and externally validated a 100‑day prognostic model for allopurinol‑induced severe cutaneous adverse reactions (SCAR). Key predictors include age, CKD stage, high initial dose, and Asian ethnicity; discrimination was good (C≈0.8).

Clinical Updates Diabetes & Endocrinology Internal Medicine news Specialties

Thyroid Hormone Levels as Predictors of Long-Term Outcomes in Chronic Critical Illness

By MedXY 08/26/2025

Low FT3 and FT4 levels in chronic critical illness correlate with increased 90-day mortality, supporting thyroid function as a valuable prognostic marker and guide for early clinical intervention.